This is willful ignorance of how this process works. I can all but guarantee you that Brilacidin for COVID will not reach the market without a big pharma partner.
Furthermore our CEO has always stuck by the plan to be a royalty company by pushing off manufacturing, distribution, marketing and pivotal regulatory work off onto a suitable partner.
The government could hand us $100M dollars tomorrow to scale up and it would likely take us years to produce the volumes needed by the world in 2021.
Just pray we succeed in the trial. A decent partnership will come of it if we do.
My apologies, I wasn't thinking partner, I was thinking buyout. it is difficult for me to see IP as a standalone company if trials are successful and B gets approved. Too many folks out there for us to think about going alone.